Related Experiment Video
Updated: Jul 7, 2026
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Precision Nanotechnology in Oral Oncology: From Biomarker-Guided Targeting to AI-Driven Theranostics
1Department of Pharmaceutics, ISF College of Pharmacy, GT Road, Moga, Punjab, 142001, India.
Abstract:
Oral squamous cell carcinoma (OSCC) is a serious malignancy characterised by poor outcomes, late identification, therapeutic resistance, and the adverse effects associated with radiation therapy, surgery, and chemotherapy. Nanotechnology-based drug delivery provides modular approaches that improve intratumoral accumulation, safeguard payloads, and facilitate controlled release, all while reducing off-target damage. This review compiles the latest findings in the field of oral cancer targeting magnetic nanomaterials, cyclodextrins, quantum dots, dendrimers, and metallic/inorganic platforms (metal-organic frameworks). Mechanistic innovations encompass both passive and active targeting strategies (e.g., EGFR, folate, CD44), stimuliresponsive mechanisms (pH, enzyme), and precision systems guided by salivary biomarkers (e.g., IL-8, CYFRA 21-1), ultimately leading to enhanced therapeutic indices and real-time theranostic monitoring. Innovative approaches use AI-driven design, biosensor-facilitated early detection, and Nanovaccine/immunenanomedicine techniques to personalise treatment in the multifaceted oral tumour microenvironment. Translational challenges remain, including heterogeneous EPR effects, nanotoxicology (encompassing autophagy and ROS pathways), manufacturing scale-up, and regulatory standardisation. These issues require the development of robust pharmacology-toxicity frameworks and biomarker-driven clinical trials. Nanocarriers of the future may revolutionise OSCC treatment by bringing together materials science, tumour biology, and genetic and salivary signals that are unique to each patient. This will allow for safer, more effective, and quantifiable precision therapies.
Insights
Nanotechnology offers advanced drug delivery for oral cancer, improving treatment efficacy and reducing side effects. Future nanocarriers promise personalized, safer therapies by integrating material science and patient-specific biological signals.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Oncology
Background:
- Oral squamous cell carcinoma (OSCC) presents significant challenges due to poor outcomes, late detection, and treatment resistance.
- Current therapies like radiation, surgery, and chemotherapy have severe adverse effects.
- Nanotechnology-based drug delivery systems show promise for improving OSCC treatment by enhancing drug accumulation and reducing toxicity.
Purpose of the Study:
- To review recent advancements in nanotechnology for oral cancer targeting.
- To explore innovative targeting strategies, stimuli-responsive mechanisms, and theranostic applications.
- To discuss emerging approaches like AI-driven design, biosensor-based detection, and nanovaccines for personalized OSCC treatment.
Main Methods:
- Review of current literature on magnetic nanomaterials, cyclodextrins, quantum dots, dendrimers, and metal-organic frameworks for OSCC.
- Analysis of passive and active targeting strategies (e.g., EGFR, folate, CD44).
- Examination of stimuli-responsive systems (pH, enzyme) and salivary biomarker-guided precision systems (IL-8, CYFRA 21-1).
Main Results:
- Nanomaterials enhance intratumoral drug accumulation, payload protection, and controlled release, minimizing off-target effects.
- Innovative strategies include AI-driven design, biosensor-based early detection, and nanovaccines for personalized therapy.
- Theranostic monitoring and enhanced therapeutic indices are achievable through advanced nanocarrier designs.
Conclusions:
- Nanotechnology holds significant potential to revolutionize OSCC treatment, offering safer, more effective, and quantifiable precision therapies.
- Future nanocarriers will integrate materials science, tumor biology, and patient-specific genetic/salivary signals for personalized medicine.
- Addressing translational challenges like nanotoxicology, scale-up, and regulatory standardization is crucial for clinical implementation.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...